Literature DB >> 7851387

Cloning and primary structure of murine 11 beta-hydroxysteroid dehydrogenase/microsomal carbonyl reductase.

U C Oppermann1, K J Netter, E Maser.   

Abstract

Screening of a mouse liver lambda gt 11 cDNA library with a rat liver 11 beta-hydroxysteroid dehydrogenase cDNA (11 beta-HSDr1A) and subsequent screening with an isolated mouse probe, resulted in the isolation and structure determination of a mouse cDNA encoding an amino acid sequence which is very similar to human and rat 11 beta-hydroxysteroid dehydrogenases (78% and 86% similar, respectively), and also to other known vertebrate 11 beta-hydroxysteroid dehydrogenase structures. Open-reading-frame analysis and the deduced amino acid sequence predict a protein with a molecular mass of 32.3 kDa which belongs to the superfamily of the short-chain dehydrogenase proteins. The amino acid sequence contains two potential glycosylation sites. These data are in agreement with information on the glycoprotein character of the native enzyme. This kind of post-translational modification seems to be a determining factor concerning the equilibrium of the catalyzed 11 beta-dehydrogenation/11-oxo reduction step [Obeid, J., Curnow, K. M., Aisenberg, J. & White, P.C. (1993) Mol. Endocrinol. 7, 154-160; Agarwal, A.K., Tusie-Luna, M.T., Monder, C. & White, P.C. (1990) Mol. Endocrinol. 4, 1827-1832]. After in vitro transcription/translation of the mouse cDNA, immunoprecipitation with anti-(microsomal carbonyl reductase) serum and N-terminal sequence analysis of the purified protein confirms the identity of microsomal 11 beta-hydroxysteroid dehydrogenase with the previously described, microsomal-bound xenobiotic carbonyl reductase [Maser, E. & Bannenberg, G. (1994) Biochem. Pharmacol. 47, 1805-1812], and points to an involvement of the 11 beta-HSD1A isoform in the reductive phase-I metabolism of xenobiotic compounds, besides its endocrinological functions. The alignment and comparison to other hydroxysteroid dehydrogenase forms of the same protein superfamily allows the identification of important residues in the 11 beta-HSD primary structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851387     DOI: 10.1111/j.1432-1033.1995.tb20377.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Characterization of 11β-hydroxysteroid dehydrogenase activities in the renal cell line LLC-PK(1) : Evidence for a third isoform?

Authors:  E Möbus; J J Rob Hermans; E Maser
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

2.  Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells.

Authors:  Mei-Fway Iu; Hiroshi Kaji; Junko Naito; Hideaki Sowa; Toshitsugu Sugimoto; Kazuo Chihara
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

3.  Purification of 11 beta-hydroxysteroid dehydrogenase type 2 from human placenta utilizing a novel affinity labelling technique.

Authors:  R W Brown; K E Chapman; P Murad; C R Edwards; J R Seckl
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

4.  Dysregulation of glucocorticoid metabolism in murine obesity: comparable effects of leptin resistance and deficiency.

Authors:  Dawn E W Livingstone; Sarah L Grassick; Gillian L Currie; Brian R Walker; Ruth Andrew
Journal:  J Endocrinol       Date:  2009-02-17       Impact factor: 4.286

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.